Nephro Care India's Q4 FY 2025-26 Quarterly Results

Result Summary

• Nephro Care India Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
• Its expenses for the quarter were - by - QoQ and - - YoY.
• The net profit - - QoQ and - - YoY.
• The earnings per share (EPS) of Nephro Care India Ltd stood at 0.61 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Nephro Care India Ltd is a company that provides healthcare services, primarily focusing on nephrology, which involves the care and treatment of kidney-related diseases. The company operates within the healthcare sector, offering specialized medical services and products that cater to patients with renal conditions. As a key player in the healthcare industry, Nephro Care India Ltd is committed to delivering high-quality patient care through innovative treatment solutions and state-of-the-art facilities. The company also emphasizes research and development to advance treatment methodologies in nephrology. Currently, there is no specific information available regarding recent major developments within the company.

Revenue

In the fourth quarter of the fiscal year 2026 (Q4FY26), Nephro Care India Ltd reported a total income of ₹27.58 crores. This figure represents the company's revenue from its operations during this period. The data provided does not include comparative figures for the third quarter of fiscal year 2026 (Q3FY26) or the fourth quarter of fiscal year 2025 (Q4FY25), and therefore, changes in revenue on a quarter-over-quarter (QoQ) or year-over-year (YoY) basis cannot be determined from the given dataset. As the only available data point, the total income for Q4FY26 provides a snapshot of the company's revenue-generating capacity during this specific quarter.

Profitability

In terms of profitability, Nephro Care India Ltd recorded a profit before tax of ₹1.30 crores for Q4FY26. After accounting for taxes amounting to ₹0.29 crores, the company reported a profit after tax of ₹1.00 crore. The earnings per share for this period were ₹0.61. As with the revenue data, the absence of previous quarter and year figures precludes any calculation of QoQ or YoY changes in profitability metrics. The data solely provides insight into the company's profitability for Q4FY26, highlighting the net profit achieved after tax obligations were settled.

Operating Metrics

The operating metrics for Nephro Care India Ltd, as derived from the available financial data, indicate total expenses of ₹26.27 crores for Q4FY26. This reflects the costs incurred by the company in the course of its business operations during the quarter. The dataset does not provide specific details on other operating metrics such as operational efficiency ratios or cost breakdowns. Consequently, no analysis of operational performance over different periods can be conducted with the current data. The report focuses on the stated expenses as a key indicator of the company's operational activities for the specified quarter.